Anne Santerre Henriksen, PhD

Acting EVP of Clinical Development
Utility Therapeutics, Denmark

Disclosure(s): UTILITY therapeutics Ltd: Advisor/Consultant

Anne has more than 20 years experience in the pharmaceutical industry, spanning roles in medical affairs, research, clinical development, scientific communication and business development (LEO Pharma A/S, Basilea Phamaceutica Ltd, UNION therapeutics A/S, UTILITY therapeutics Ltd).
Academic authorship of numerous journal articles within the fields of research and development of anti-infectives.
Anne holds a Ph.D in Microbiology from Institut National des Sciences Appliquées de Toulouse, France.

Poster(s):

• 1678 - Activity of mecillinam against urinary tract clinical isolates from the United States during 2017-2020 including isolates resistant to comparator antibiotics and multi-drug resistant isolates
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET